Loading clinical trials...
Loading clinical trials...
The primary objectives of this study are: * To determine whether rivaroxaban 2.5 mg twice daily (bid) + aspirin 100 mg once daily (od) compared with aspirin 100 mg od reduces the risk of a composite ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
Collaborators
NCT07232069 · Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, and more
NCT06164600 · Urinary Tract Infections, Recurrent, and more
NCT07237360 · Unexpected Infant Death, Prevention & Control, and more
NCT05504434 · Gastroscopy, Esophagogastroduodenoscopy, and more
NCT05365737 · Prevention & Control
Birmingham, Alabama
Mobile, Alabama
Anaheim, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions